Sherriff, I believe the trial numbers may have been limited already by the amount of drug the company has left. I'm far from certain on this but recall hearing or reading a comment on this In the past. If this is the case, I suggest that an expanded trial would be unlikely.
INV103 - Results Due in July !, page-7
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $13.53M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $52.22K | 17.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 55 | 54807402 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 8956699 | 13 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| IVX (ASX) Chart |